MicroRNA gene dosage alterations and drug response in lung cancer

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Enfield, Katey S S ^a   Stewart, Greg L ^a   Pikor, Larissa A ^a   Alvarez, Carlos E ^b   Lam, Stephen ^a   Lam, Wan L ^a   Chari, Raj ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA KINASE INHIBITOR; AZ 628; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CRIZOTINIB; GELDANAMYCIN; MESSENGER RNA; MICRORNA; MICRORNA 10B; MICRORNA 193B; MICRORNA 328; MICRORNA 628; TOZASERTIB; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER RESISTANCE; DRUG RESPONSE; GENE DOSAGE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; HUMAN; IC 50; LUNG CANCER; NONHUMAN; RNA ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENETICS; LUNG TUMOR; METABOLISM; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA, MESSENGER;

EID: 79959334980     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/474632     Document Type: Article

References (92)

1. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010 CA: Cancer Journal for Clinicians 2010 60 5 277 300
2. Wakelee H., Belani C. P., Optimizing first-line treatment options for patients with advanced NSCLC Oncologist 2005 10 3 1 10 (Pubitemid 43152725)
3. Scagliotti G., Hanna N., Fossella F., Sugarman K., Blatter J., Peterson P., Simms L., Shepherd F. A., The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies Oncologist 2009 14 3 253 263
4. Fukuoka M., Yano S., Giaccone G., Tamura T., Nakagawa K., Douillard J.-Y., Nishiwaki Y., Vansteenkiste J., Kudoh S., Rischin D., Eek R., Horai T., Noda K., Takata I., Smit E., Averbuch S., Macleod A., Feyereislova A., Dong R.-P., Baselga J., Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer Journal of Clinical Oncology 2003 21 12 2237 2246 (Pubitemid 46621858)
5. Mok T. S., Wu Y. L., Thongprasert S., Yang C. H., Chu D. T., Saijo N., Sunpaweravong P., Han B., Margono B., Ichinose Y., Nishiwaki Y., Ohe Y., Yang J. J., Chewaskulyong B., Jiang H., Duffield E. L., Watkins C. L., Armour A. A., Fukuoka M., Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma The New England Journal of Medicine 2009 361 10 947 957
6. Sos M. L., Michel K., Zander T., Weiss J., Frommolt P., Peifer M., Li D., Ullrich R., Koker M., Fischer F., Shimamura T., Rauh D., Mermel C., Fischer S., Stckrath I., Heynck S., Beroukhim R., Lin W., Winckler W., Shah K., LaFramboise T., Moriarty W. F., Hanna M., Tolosi L., Rahnenfhrer J., Verhaak R., Chiang D., Getz G., Hellmich M., Wolf J., Girard L., Peyton M., Weir B. A., Chen T. H., Greulich H., Barretina J., Shapiro G. I., Garraway L. A., Gazdar A. F., Minna J. D., Meyerson M., Wong K. K., Thomas R. K., Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions Journal of Clinical Investigation 2009 119 6 1727 1740
7. Kwak E. L., Bang Y.-J., Camidge D. R., Shaw A. T., Solomon B., Maki R. G., Ou S.-H. I., Dezube B. J., Jnne P. A., Costa D. B., Varella-Garcia M., Kim W.-H., Lynch T. J., Fidias P., Stubbs H., Engelman J. A., Sequist L. V., Tan W., Gandhi L., Mino-Kenudson M., Wei G. C., Shreeve S. M., Ratain M. J., Settleman J., Christensen J. G., Haber D. A., Wilner K., Salgia R., Shapiro G. I., Clark J. W., Iafrate A. J., Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer The New England Journal of Medicine 2010 363 18 1693 1703
8. Buys T. P. H., Chari R., Lee E. H. L., Zhang M., MacAulay C., Lam S., Lam W. L., Ling V., Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells Genes Chromosomes and Cancer 2007 46 12 1069 1079 (Pubitemid 47614541)
9. Etemadmoghadam D., Defazio A., Beroukhim R., Mermel C., George J., Getz G., Tothiil R., Okamoto A., Raeder M. B., Harnett P., Lade S., Akslen L. A., Tinker A. V., Locandro B., Aisop K., Chiew Y. E., Traficante N., Fereday S., Johnson D., Fox S., Sellers W., Urashima M., Salvesen H. B., Meyerson M., Bowtell D., Integrated genome-wide DMA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas Clinical Cancer Research 2009 15 4 1417 1427
10. Kobayashi S., Boggon T. J., Dayaram T., Jnne P. A., Kocher O., Meyerson M., Johnson B. E., Eck M. J., Tenen D. G., Halmos B., EGFR mutation and resistance of non-small-cell lung cancer to gefitinib The New England Journal of Medicine 2005 352 8 786 792 (Pubitemid 40271173)
11. Pao W., Miller V. A., Politi K. A., Riely G. J., Somwar R., Zakowski M. F., Kris M. G., Varmus H., Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain PLoS Medicine 2005 2 3, article e73
12. Bianco R., Shin I., Ritter C. A., Yakes F. M., Basso A., Rosen N., Tsurutani J., Dennis P. A., Mills G. B., Arteaga C. L., Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors Oncogene 2003 22 18 2812 2822 (Pubitemid 36609595)
13. Kirschner K., Melton D. W., Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs Anticancer Research 2010 30 9 3223 3232
14. Rosell R., Felip E., Taron M., Majo J., Mendez P., Sanchez-Ronco M., Queralt C., Sanchez J. J., Maestre J., Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery Clinical Cancer Research 2004 10 12, part 2 4215s 4219s (Pubitemid 38812449)
15. Ferracin M., Veronese A., Negrini M., Micromarkers: MiRNAs in cancer diagnosis and prognosis Expert Review of Molecular Diagnostics 2010 10 3 297 308
16. Garofalo M., Condorelli G., Croce C. M., MicroRNAs in diseases and drug response Current Opinion in Pharmacology 2008 8 5 661 667
17. Hummel R., Hussey D. J., Haier J., MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types European Journal of Cancer 2010 46 2 298 311
18. Anglicheau D., Muthukumar T., Suthanthiran M., MicroRNAs: small RNAs with big effects Transplantation 2010 90 2 105 112
19. Shyu A. B., Wilkinson M. F., van Hoof A., Messenger RNA regulation: to translate or to degrade The EMBO Journal 2008 27 3 471 481 (Pubitemid 351225677)
20. Calin G. A., Croce C. M., MicroRNA signatures in human cancers Nature Reviews Cancer 2006 6 11 857 866 (Pubitemid 44629897)
21. Garzon R., Calin G. A., Croce C. M., MicroRNAs in cancer Annual Review of Medicine 2009 60 167 179
22. Iorio M. V., Croce C. M., MicroRNAs in cancer: small molecules with a huge impact Journal of Clinical Oncology 2009 27 34 5848 5856
23. Mallick R., Patnaik S., Yendamuri S., MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis Journal of Carcinogenesis 2010 9, article 8
24. Zhang L., Huang J., Yang N., Greshock J., Megraw M. S., Giannakakis A., Liang S., Naylor T. L., Barchetti A., Ward M. R., Yao G., Medina A., O'Brien-Jenkins A., Katsaros D., Hatzigeorgiou A., Gimotty P. A., Weber B. L., Coukos G., microRNAs exhibit high frequency genomic alterations in human cancer Proceedings of the National Academy of Sciences of the United States of America 2006 103 24 9136 9141 (Pubitemid 43902545)
25. Calin G. A., Sevignani C., Dumitru C. D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C. M., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proceedings of the National Academy of Sciences of the United States of America 2004 101 9 2999 3004 (Pubitemid 38327724)
26. Starczynowski D. T., Morin R., McPherson A., Lam J., Chari R., Wegrzyn J., Kuchenbauer F., Hirst M., Tohyama K., Humphries R. K., Lam W. L., Marra M., Karsan A., Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations Blood 2011 117 2 595 607
27. Starczynowski D. T., Kuchenbauer F., Argiropoulos B., Sung S., Morin R., Muranyi A., Hirst M., Hogge D., Marra M., Wells R. A., Buckstein R., Lam W., Humphries R. K., Karsan A., Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype Nature Medicine 2010 16 1 49 58
28. Dacic S., Kelly L., Shuai Y., Nikiforova M. N., MiRNA expression profiling of lung adenocarcinomas: correlation with mutational status Modern Pathology 2010 23 12 1577 1582
29. Wu X. M., Xiao H. S., Mirnas modulate the drug response of tumor cells Science in China, Series C 2009 52 9 797 801
30. Chuang J. C., Jones P. A., Epigenetics and microRNAs Pediatric Research 2007 61 5, part 2 24R 29R (Pubitemid 46653064)
31. Lu J., Getz G., Miska E. A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B. L., Mak R. H., Ferrando A. A., Downing J. R., Jacks T., Horvitz H. R., Golub T. R., MicroRNA expression profiles classify human cancers Nature 2005 435 7043 834 838 (Pubitemid 40839735)
32. Galluzzi L., Morselli E., Vitale I., Kepp O., Senovilla L., Criollo A., Servant N., Paccard C., Hup P., Robert T., Ripoche H., Lazar V., Harel-Bellan A., Dessen P., Barillot E., Kroemer G., miR-181a and miR-630 regulate cisplatin-induced cancer cell death Cancer Research 2010 70 5 1793 1803
33. Weiss G. J., Bemis L. T., Nakajima E., Sugita M., Birks D. K., Robinson W. A., Varella-Garcia M., Bunn P. A., Haney J., Helfrich B. A., Kato H., Hirsch F. R., Franklin W. A., EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines Annals of Oncology 2008 19 6 1053 1059 (Pubitemid 351796329)
34. Cho W. C., MicroRNAs as therapeutic targets for lung cancer Expert Opinion on Therapeutic Targets 2010 14 10 1005 1008
35. Oh J. S., Kim J. J., Byun J. Y., Kim I. A., Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras International Journal of Radiation Oncology Biology Physics 2010 76 1 5 8
36. Chari R., Coe B. P., Wedseltoft C., Benetti M., Wilson I. M., Vucic E. A., MacAulay C., Ng R. T., Lam W. L., SIGMA: a system for the integrative genomic multi-dimensional analysis of cancer genomes, epigenomes, and transcriptomes BMC Bioinformatics 2008 9, article 422
37. Rhead B., Karolchik D., Kuhn R. M., Hinrichs A. S., Zweig A. S., Fujita P. A., Diekhans M., Smith K. E., Rosenbloom K. R., Raney B. J., Pohl A., Pheasant M., Meyer L. R., Learned K., Hsu F., Hillman-Jackson J., Harte R. A., Giardine B., Dreszer T. R., Clawson H., Barber G. P., Haussler D., Kent W. J., The UCSC genome browser database: update 2010 Nucleic Acids Research 2009 38 1, database issue D613 D619
38. Irizarry R. A., Hobbs B., Collin F., Beazer-Barclay Y. D., Antonellis K. J., Scherf U., Speed T. P., Exploration, normalization, and summaries of high density oligonucleotide array probe level data Biostatistics 2003 4 2 249 264
39. Gautier L., Cope L., Bolstad B. M., Irizarry R. A., Affyanalysis of Affymetrix GeneChip data at the probe level Bioinformatics 2004 20 3 307 315 (Pubitemid 38262761)
40. Gentleman R. C., Carey V. J., Bates D. M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A. J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J. Y., Zhang J., Bioconductor: open software development for computational biology and bioinformatics Genome Biology 2004 5 10 R80
41. Sturm M., Hackenberg M., Langenberger D., Frishman D., TargetSpy: a supervised machine learning approach for microRNA target prediction BMC Bioinformatics 2010 11, article 292
42. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 2005 120 1 15 20 (Pubitemid 40094598)
43. Grimson A., Farh K. K. H., Johnston W. K., Garrett-Engele P., Lim L. P., Bartel D. P., MicroRNA targeting specificity in mammals: determinants beyond seed pairing Molecular Cell 2007 27 1 91 105 (Pubitemid 46991392)
44. Friedman R. C., Farh K. K. H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs Genome Research 2009 19 1 92 105
45. Ma J., Dong C., Ji C., MicroRNA and drug resistance Cancer Gene Therapy 2010 17 8 523 531
46. Zheng T., Wang J., Chen X., Liu L., Role of microRNA in anticancer drug resistance International Journal of Cancer 2010 126 1 2 10
47. DeBoer C., Meulman P. A., Wnuk R. J., Peterson D. H., Geldanamycin, a new antibiotic Journal of Antibiotics 1970 23 9 442 447
48. Maes O. C., An J., Sarojini H., Wu H., Wang E., Changes in microRNA expression patterns in human fibroblasts after low-LET radiation Journal of Cellular Biochemistry 2008 105 3 824 834
49. Wilting S. M., van Boerdonk R. A. A., Henken F. E., Meijer C. J., Diosdado B., Meijer G. A., le Sage C., Agami R., Snijders P. J. F., Steenbergen R. D. M., Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer Molecular Cancer 2010 9 167
50. Silber J., Lim D. A., Petritsch C., Persson A. I., Maunakea A. K., Yu M., Vandenberg S. R., Ginzinger D. G., James C. D., Costello J. F., Bergers G., Weiss W. A., Alvarez-Buylla A., Hodgson J. G., miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells BMC Medicine 2008 6, article 14
51. Furuta M., Kozaki K. I., Tanaka S., Arii S., Imoto I., Inazawa J., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma Carcinogenesis 2009 31 5 766 776
52. Tian S., Huang S., Wu S., Guo W., Li J., He X., MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3′ untranslated region Biochemical and Biophysical Research Communications 2010 396 2 435 439
53. Kojima K., Fujita Y., Nozawa Y., Deguchi T., Ito M., MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms Prostate 2010 70 14 1501 1512
54. Zhou M., Liu Z., Zhao Y., Ding Y., Liu H., Xi Y., Xiong W., Li G., Lu J., Fodstad O., Riker A. I., Tan M., MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression Journal of Biological Chemistry 2010 285 28 21496 21507
55. Shimizu S., Takehara T., Hikita H., Kodama T., Miyagi T., Hosui A., Tatsumi T., Ishida H., Noda T., Nagano H., Doki Y., Mori M., Hayashi N., The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma Journal of Hepatology 2010 52 5 698 704
56. Bai S., Nasser M. W., Wang B., Hsu S. H., Datta J., Kutay H., Yadav A., Nuovo G., Kumar P., Ghoshal K., MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib Journal of Biological Chemistry 2009 284 46 32015 32027
57. Braconi C., Valeri N., Gasparini P., Huang N., Taccioli C., Nuovo G., Suzuki T., Croce C. M., Patel T., Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes Clinical Cancer Research 2010 16 3 957 966
58. Sorrentino A., Liu C. G., Addario A., Peschle C., Scambia G., Ferlini C., Role of microRNAs in drug-resistant ovarian cancer cells Gynecologic Oncology 2008 111 3 478 486
59. San Jos-Enriz E., Romn-Gmez J., Jimnez-Velasco A., Garate L., Martin V., Cordeu L., Vilas-Zornoza A., Rodrguez-Otero P., Jos Calasanz M., Prsper F., Agirre X., MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations Molecular Cancer 2009 8, article 1476 69
60. Coe B. P., Chari R., Lockwood W. W., Lam W. L., Evolving strategies for global gene expression analysis of cancer Journal of Cellular Physiology 2008 217 3 590 597
61. Luo B., Hiu W. C., Subramanian A., Sharifnia T., Okamoto M., Yang X., Hinkle G., Boehm J. S., Beroukhim R., Weir B. A., Mermel C., Barbie D. A., Awad T., Zhou X., Nguyen T., Piqani B., Li C., Golub T. R., Meyerson M., Hacohen N., Hahn W. C., Lander E. S., Sabatini D. M., Root D. E., Highly parallel identification of essential genes in cancer cells Proceedings of the National Academy of Sciences of the United States of America 2008 105 51 20380 20385
62. Ma L., Teruya-Feldstein J., Weinberg R. A., Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 2007 449 7163 682 688 (Pubitemid 47552092)
63. Jukic D. M., Rao U. N. M., Kelly L., Skaf J. S., Drogowski L. M., Kirkwood J. M., Panelli M. C., Microrna profiling analysis of differences between the melanoma of young adults and older adults Journal of Translational Medicine 2010 8, article 27
64. Sasayama T., Nishihara M., Kondoh T., Hosoda K., Kohmura E., MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC International Journal of Cancer 2009 125 6 1407 1413
65. Dahiya N., Sherman-Baust C. A., Wang T. L., Davidson B., Shih L. M., Zhang Y., Wood W., Becker K. G., Morin P. J., MicroRNA expression and identification of putative miRNA targets in ovarian cancer PLoS One 2008 3 6
66. Li X., Zhang Y., Zhang Y., Ding J., Wu K., Fan D., Survival prediction of gastric cancer by a seven-microRNA signature Gut 2010 59 5 579 585
67. Prueitt R. L., Yi M., Hudson R. S., Wallace T. A., Howe T. M., Yfantis H. G., Lee D. H., Stephens R. M., Liu C. G., Calin G. A., Croce C. M., Ambs S., Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer Prostate 2008 68 11 1152 1164
68. Ma L., Reinhardt F., Pan E., Soutschek J., Bhat B., Marcusson E. G., Teruya-Feldstein J., Bell G. W., Weinberg R. A., Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nature Biotechnology 2010 28 4 341 347
69. Bai H., Madabushi A., Guan X., Lu A. L., Interaction between human mismatch repair recognition proteins and checkpoint sensor Rad9-Rad1-Hus1 DNA Repair 2010 9 5 478 487
70. Han L., Hu Z., Liu Y., Wang X., Hopkins K. M., Lieberman H. B., Hang H., Mouse Rad1 deletion enhances susceptibility for skin tumor development Molecular Cancer 2010 9, article 67
71. Olaussen K. A., Dunant A., Fouret P., Brambilla E., Andr F., Haddad V., Taranchon E., Filipits M., Pirker R., Popper H. H., Stahel R., Sabatier L., Pignon J. P., Tursz T., Le Chevalier T., Soria J. C., DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy The New England Journal of Medicine 2006 355 10 983 991 (Pubitemid 44343542)
72. Sabatino M. A., Marabese M., Ganzinelli M., Caiola E., Geroni C., Broggini M., Down-regulation of the nucleotide excision repair gene XPG as a new mechanism of drug resistance in human and murine cancer cells Molecular Cancer 2010 9, article 259
73. Ding Z., Zhang J., Shao J., ERCC1 expression as a predictor of survival after operation in stage I non-small cell lung cancer patients Zhongguo Fei Ai Za Zhi 2010 13 5 522 525
74. Avissar M., Christensen B. C., Kelsey K. T., Marsit C. J., MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma Clinical Cancer Research 2009 15 8 2850 2855
75. Worley L. A., Long M. D., Onken M. D., Harbour J. W., Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling Melanoma Research 2008 18 3 184 190 (Pubitemid 351684663)
76. Li X. F., Yan P. J., Shao Z. M., Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer Oncogene 2009 28 44 3937 3948
77. Rauhala H. E., Jalava S. E., Isotalo J., Bracken H., Lehmusvaara S., Tammela T. L. J., Oja H., Visakorpi T., miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer International Journal of Cancer 2010 127 6 1363 1372
78. Caramuta S., Egyhzi S., Rodolfo M., Witten D., Hansson J., Larsson C., Lui W. O., MicroRNA expression profiles associated with mutational status and survival in malignant melanoma Journal of Investigative Dermatology 2010 130 8 2062 2070
79. Chen J., Feilotter H. E., Par G. C., Zhang X., Pemberton J. G. W., Garady C., Lai D., Yang X., Tron V. A., MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma American Journal of Pathology 2010 176 5 2520 2529
80. Kim J., Sif S., Jones B., Jackson A., Koipally J., Heller E., Winandy S., Viel A., Sawyer A., Ikeda T., Kingston R., Georgopoulos K., Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes Immunity 1999 10 3 345 355 (Pubitemid 29165289)
81. Kuiper R. P., Waanders E., van der Velden V. H. J., van Reijmersdal S. V., Venkatachalam R., Scheijen B., Sonneveld E., van Dongen J. J. M., Veerman A. J. P., van Leeuwen F. N., Geurts van Kessel A., Hoogerbrugge P. M., IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL Leukemia 2010 24 7 1258 1264
82. Joha S., Dauphin V., Leprtre F., Corm S., Nicolini F. E., Roumier C., Nibourel O., Grardel N., Maguer-Satta V., Idziorek T., Figeac M., La J.-L., Quesnel B., Etienne G., Guilhot F., Lippert E., Preudhomme C., Roche-Lestienne C., Genomic characterization of Imatinib resistance in CD34 + cell populations from chronic myeloid leukaemia patients. Leukemia Research. In press
83. Lacobucci I., Lonetti A., Messa F., Cilloni D., Arruga F., Ottaviani E., Paolini S., Papayannidis C., Piccaluga P. P., Giannoulia P., Soverini S., Amabile M., Poerio A., Saglio G., Pane F., Berton G., Baruzzi A., Vitale A., Chiaretti S., Perini G., Fo R., Baccarani M., Martinelli G., Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance Blood 2008 112 9 3847 3855
84. Li W.-Q., Li Y.-M., Tao B.-B., Lu Y.-C., Hu G.-H., Liu H.-M., He J., Xu Y., Yu H.-Y., Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance Case Reports and Clinical Practice Review 2010 16 10 HY27 HY30
85. Malzkorn B., Wolter M., Liesenberg F., Grzendowski M., Sthler K., Meyer H. E., Reifenberger G., Identification and functional characterization of microRNAs involved in the malignant progression of gliomas Brain Pathology 2010 20 3 539 550
86. Pan Y. Z., Morris M. E., Yu A. M., MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells Molecular Pharmacology 2009 75 6 1374 1379
87. Krishnan A. V., Feldman D., Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D Annual Review of Pharmacology and Toxicology 2011 51 311 336
88. Srinivasan M., Parwani A. V., Hershberger P. A., Lenzner D. E., Weissfeld J. L., Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer Journal of Steroid Biochemistry and Molecular Biology 2011 123 1-2 30 36
89. Sonveaux P., Vgran F., Schroeder T., Wergin M. C., Verrax J., Rabbani Z. N., De Saedeleer C. J., Kennedy K. M., Diepart C., Jordan B. F., Kelley M. J., Gallez B., Wahl M. L., Feron O., Dewhirst M. W., Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice Journal of Clinical Investigation 2008 118 12 3930 3942
90. Schulte J. H., Marschall T., Martin M., Rosenstiel P., Mestdagh P., Schlierf S., Thor T., Vandesompele J., Eggert A., Schreiber S., Rahmann S., Schramm A., Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma Nucleic Acids Research 2010 38 17 5919 5928
91. Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T. T., Yu V. L., Miller D. K., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 1995 376 6535 37 43
92. Zou H. Y., Li Q., Lee J. H., Arango M. E., McDonnell S. R., Yamazaki S., Koudriakova T. B., Alton G., Cui J. J., Kung P. P., Nambu M. D., Los G., Bender S. L., Mroczkowski B., Christensen J. G., An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms Cancer Research 2007 67 9 4408 4417 (Pubitemid 46815090)